These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 25968067

  • 1. MAPK inhibitors modulate Smad2/3/4 complex cyto-nuclear translocation in myofibroblasts via Imp7/8 mediation.
    Jiang Y, Wu C, Boye A, Wu J, Wang J, Yang X, Yang Y.
    Mol Cell Biochem; 2015 Aug; 406(1-2):255-62. PubMed ID: 25968067
    [Abstract] [Full Text] [Related]

  • 2. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
    Boye A, Wu C, Jiang Y, Wang J, Wu J, Yang X, Yang Y.
    J Ethnopharmacol; 2015 Jul 01; 169():219-28. PubMed ID: 25934513
    [Abstract] [Full Text] [Related]

  • 3. Mitogen-activated protein kinase inhibitors reduce the nuclear accumulation of phosphorylated Smads by inhibiting Imp 7 or Imp 8 in HepG2 cells.
    Hu X, Kan H, Boye A, Jiang Y, Wu C, Yang Y.
    Oncol Lett; 2018 Apr 01; 15(4):4867-4872. PubMed ID: 29552126
    [Abstract] [Full Text] [Related]

  • 4. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
    Wu C, Chen W, Ding H, Li D, Wen G, Zhang C, Lu W, Chen M, Yang Y.
    Life Sci; 2019 Dec 15; 239():116881. PubMed ID: 31678285
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
    He S, Liu X, Yang Y, Huang W, Xu S, Yang S, Zhang X, Roberts MS.
    Br J Dermatol; 2010 Mar 15; 162(3):538-46. PubMed ID: 19772524
    [Abstract] [Full Text] [Related]

  • 6. MAPK inhibitors differently modulate TGF-β/Smad signaling in HepG2 cells.
    Boye A, Kan H, Wu C, Jiang Y, Yang X, He S, Yang Y.
    Tumour Biol; 2015 May 15; 36(5):3643-51. PubMed ID: 25560488
    [Abstract] [Full Text] [Related]

  • 7. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts.
    Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, Yamagata H, Matsushita M, Seki T, Inagaki Y, Nishizawa M, Fujisawa J, Inoue K.
    Hepatology; 2003 Oct 15; 38(4):879-89. PubMed ID: 14512875
    [Abstract] [Full Text] [Related]

  • 8. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells.
    Guo B, Inoki K, Isono M, Mori H, Kanasaki K, Sugimoto T, Akiba S, Sato T, Yang B, Kikkawa R, Kashiwagi A, Haneda M, Koya D.
    Kidney Int; 2005 Sep 15; 68(3):972-84. PubMed ID: 16105028
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
    Wakahara K, Kobayashi H, Yagyu T, Matsuzaki H, Kondo T, Kurita N, Sekino H, Inagaki K, Suzuki M, Kanayama N, Terao T.
    J Cell Biochem; 2004 Oct 15; 93(3):437-53. PubMed ID: 15372629
    [Abstract] [Full Text] [Related]

  • 11. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts.
    Yang Y, Yang S, Chen M, Zhang X, Zou Y, Zhang X.
    J Ethnopharmacol; 2008 Jul 23; 118(2):264-70. PubMed ID: 18502066
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism.
    Rodríguez-Vita J, Sánchez-López E, Esteban V, Rupérez M, Egido J, Ruiz-Ortega M.
    Circulation; 2005 May 17; 111(19):2509-17. PubMed ID: 15883213
    [Abstract] [Full Text] [Related]

  • 13. Histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide attenuates plasminogen activator inhibitor-1 expression in human pleural mesothelial cells.
    Chung CL, Sheu JR, Chen WL, Chou YC, Hsiao CJ, Hsiao SH, Hsu MJ, Cheng YW, Hsiao G.
    Am J Respir Cell Mol Biol; 2012 Apr 17; 46(4):437-45. PubMed ID: 22033265
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, Ryu BK, Park YK, Chi SG.
    Oncogene; 2003 Jul 10; 22(28):4314-32. PubMed ID: 12853969
    [Abstract] [Full Text] [Related]

  • 15. Regulation of TGF-beta1/MAPK-mediated PAI-1 gene expression by the actin cytoskeleton in human mesangial cells.
    Yang C, Patel K, Harding P, Sorokin A, Glass WF.
    Exp Cell Res; 2007 Apr 01; 313(6):1240-50. PubMed ID: 17328891
    [Abstract] [Full Text] [Related]

  • 16. Molecular validation of the precision-cut kidney slice (PCKS) model of renal fibrosis through assessment of TGF-β1-induced Smad and p38/ERK signaling.
    Zhang S, Liu Q, Xiao J, Lei J, Liu Y, Xu H, Hong Z.
    Int Immunopharmacol; 2016 May 01; 34():32-36. PubMed ID: 26919280
    [Abstract] [Full Text] [Related]

  • 17. Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.
    Samarakoon R, Higgins PJ.
    Thromb Haemost; 2008 Dec 01; 100(6):976-83. PubMed ID: 19132220
    [Abstract] [Full Text] [Related]

  • 18. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S, Yang Y, Liu X, Huang W, Zhang X, Yang S, Zhang X.
    Br J Dermatol; 2012 Mar 01; 166(3):564-74. PubMed ID: 21967214
    [Abstract] [Full Text] [Related]

  • 19. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
    Liu X, Yang Y, Zhang X, Xu S, He S, Huang W, Roberts MS.
    J Gastroenterol Hepatol; 2010 Feb 01; 25(2):420-6. PubMed ID: 19793165
    [Abstract] [Full Text] [Related]

  • 20. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
    Chen LX, Yang K, Sun M, Chen Q, Wang ZH, Hu GY, Tao LJ.
    Pharmazie; 2012 May 01; 67(5):452-6. PubMed ID: 22764581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.